Search
Displaying results 701 to 710 of 1201.
A common European strategy against COVID-19
Control of the coronavirus pandemic by vaccines, which are currently close to approval, is not expected until later in 2021. Until then, SARS-CoV-2 case numbers must be controlled through non-pharmaceutical measures such as contact reductions, hygiene measures and case…
Corona: How the virus interacts with cells
In the biosafety level 3 suite at HIRI, the scientists infected human cells with the new coronavirus, which uses RNA as genetic material. In a second step, they purified the viral RNA and identified the proteins bound to it. "Mass spectrometry allows us to accurately…
Leibniz Prize 2021 for Rolf Müller
“I am very pleased about the great honour for Rolf Müller and the recognition of his many years of research work. I would like to congratulate him very warmly on behalf of the entire HZI,” said Prof Dirk Heinz, Scientific Director of the HZI. “Rolf Müller is one of the…
Federal government decides on million-euro funding for HIPS
The Federal Budget Committee has assured the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) funding of 47 million euros for the further expansion of the institute. Together with funds from the state of Saarland, the HIPS will receive a total of 70…
Important step in fighting resistant bacteria
Its metabolism and the structure of its cellular membrane render the hospital germ Pseudomonas aeruginosa resistant against several antibiotics. P . aeruginosa is responsible for around ten percent of all hospital infections, making it one of the most common…
Two HZI scientists honoured as “Highly-cited researchers”
Prof Jörg Vogel is founding director of the Helmholtz Institute for RNA-based Infection Research (HIRI), a site of the Helmholtz Centre for Infection Research (HZI) with the Julius-Maximilians-Universität Würzburg (JMU). His research group “RNA biology of bacterial…
Funding for the development of an inhibitor against hospital germs
Bacteria of the species Staphylococcus aureus are among the most common pathogens associated with hospital-acquired pneumonia worldwide. Multi-resistant strains of this pathogen have spread worldwide and constitute a major threat for health care, especially in countries…
Coinfection: More than the sum of its parts
Organ and stem cell transplants are proven and frequently used methods in everyday modern clinical practice. However, even when performed regularly in specialised centres, some patients still experience a number of serious complications afterwards. Among other things,…
Jörg Vogel announced as new president of the Academy of Microbiology
About Professor Vogel Jörg Vogel spent part of his undergraduate studies in Biochemistry at Imperial College London, UK and graduated from Humboldt University, Germany; where he also went on to pursue his PhD with a thesis on Group II intron splicing. He subsequently…
Two murine restriction factors limiting hepatitis C infection described
HCV remains a global health problem in 2020. The World Health Organisation (WHO) estimates that around 71 million people worldwide are infected with the virus. Infections often remain undetected because they rarely cause severe acute symptoms. However, serious damage to…